Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial

Published:2013-09 Issue:9 Volume:15 Page:1053-1061
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Ferreira Jorge¹,Ezekowitz Michael D.²,Connolly Stuart J.³,Brueckmann Martina⁴⁵,Fraessdorf Mandy⁴,Reilly Paul A.⁶,Yusuf Salim³,Wallentin Lars⁷,

Affiliation:

1. Hospital Santa Cruz; Lisbon Portugal

2. Thomas Jefferson Medical College; Wynnewood PA USA

3. Population Health Research Institute; McMaster University and Hamilton Health Sciences; Hamilton Canada

4. Boehringer Ingelheim GmbH & Co. KG; Ingelheim Germany

5. Faculty of Medicine Mannheim; University of Heidelberg; Mannheim Germany

6. Boehringer Ingelheim Pharmaceuticals Inc.; Ridgefield CT USA

7. Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center; Uppsala University; Uppsala Sweden

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hft111/fullpdf

Reference31 articles.

1. The heart failure epidemic: exactly how big is it?;Cleland;Eur Heart J,2001

2. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation;Nieuwlaat;J Am Coll Cardiol,2009

3. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy;Maisel;Am J Cardiol,2003

4. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction;Dries;J Am Coll Cardiol,1998

5. Stroke in AF working group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review;Neurology,2007

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Novel Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis;Cureus;2024-05-30

2. Clinical outcomes and anticoagulation therapy in elderly non‐valvular atrial fibrillation and heart failure patients;ESC Heart Failure;2024-01-11

3. Oral anticoagulation in heart failure complicated by atrial fibrillation: A nationwide routine data study;International Journal of Cardiology;2024-01

4. A review of the impact, pathophysiology, and management of atrial fibrillation in patients with heart failure with preserved ejection fraction;American Heart Journal Plus: Cardiology Research and Practice;2023-09

5. Oral anticoagulation in heart failure complicated by atrial fibrillation: Outcomes in routine data;2023-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3